Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Bioavailability testing of a newly developed clindamycin oral suspension in a pediatric porcine model.

Goode GA, Wagh SJ, Irby DJ, Ma D, Jacobs RF, Kearns GL, Almoazen H.

Pharm Dev Technol. 2019 Oct;24(8):1038-1043. doi: 10.1080/10837450.2019.1624771. Epub 2019 Jun 21.

PMID:
31134840
2.

Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.

Marsico C, Aban I, Kuo H, James SH, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth S, Jester PM, Whitley RJ, Kimberlin DW; Collaborative Antiviral Study Group (CASG).

J Infect Dis. 2019 Apr 16;219(9):1398-1406. doi: 10.1093/infdis/jiy695.

PMID:
30535363
3.

An Adaptable Pediatrics Faculty Mentoring Model.

Cranmer JM, Scurlock AM, Hale RB, Ward WL, Prodhan P, Weber JL, Casey PH, Jacobs RF.

Pediatrics. 2018 May;141(5). pii: e20173202. doi: 10.1542/peds.2017-3202. Epub 2018 Apr 18.

4.

Hospitalist Medicine-Chairs' Perspective of Specialty Status and Training Requirements.

Clapp DW, Quattrin T, Jacobs RF, Opipari VC.

J Pediatr. 2018 Feb;193:4-8.e1. doi: 10.1016/j.jpeds.2017.11.049. No abstract available.

PMID:
29389453
5.

Variation in Tularemia Clinical Manifestations-Arkansas, 2009-2013.

Lester Rothfeldt LK, Jacobs RF, Wheeler JG, Weinstein S, Haselow DT.

Open Forum Infect Dis. 2017 Feb 15;4(1):ofx027. doi: 10.1093/ofid/ofx027. eCollection 2017 Winter.

6.

Association of Medical School Pediatric Department Chairs Principles of Lifelong Learning in Pediatric Medicine.

Opipari VP, Daniels SR, Wilmott RW, Jacobs RF.

JAMA Pediatr. 2016 Nov 1;170(11):1087-1092. doi: 10.1001/jamapediatrics.2016.2258.

PMID:
27654621
7.

Evaluation of a Mentoring Program for New Pediatric Department Chairs.

Wilmott RW, Abramson JS, Davies HD, Felice ME, Stanton B, Jacobs RF.

J Pediatr. 2015 Oct;167(4):787-8. doi: 10.1016/j.jpeds.2015.06.069. No abstract available.

PMID:
26409762
8.

A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.

Abzug MJ, Michaels MG, Wald E, Jacobs RF, Romero JR, Sánchez PJ, Wilson G, Krogstad P, Storch GA, Lawrence R, Shelton M, Palmer A, Robinson J, Dennehy P, Sood SK, Cloud G, Jester P, Acosta EP, Whitley R, Kimberlin D; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

J Pediatric Infect Dis Soc. 2016 Mar;5(1):53-62. doi: 10.1093/jpids/piv015. Epub 2015 Apr 16.

9.

Valganciclovir for symptomatic congenital cytomegalovirus disease.

Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

N Engl J Med. 2015 Mar 5;372(10):933-43. doi: 10.1056/NEJMoa1404599.

10.

Vaccine policy and Arkansas childhood immunization exemptions: a multi-year review.

Safi H, Wheeler JG, Reeve GR, Ochoa E, Romero JR, Hopkins R, Ryan KW, Jacobs RF.

Am J Prev Med. 2012 Jun;42(6):602-5. doi: 10.1016/j.amepre.2012.02.022.

PMID:
22608376
11.

A conversation with Richard F. Jacobs, MD, FAAP. Interview by Stanford T. Shulman.

Jacobs RF.

Pediatr Ann. 2012 Feb;41(2):83. doi: 10.3928/00904481-20120110-14. No abstract available.

PMID:
22300187
12.

Oral acyclovir suppression and neurodevelopment after neonatal herpes.

Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, Palmer A, Sánchez PJ, Jacobs RF, Bradley JS, Robinson JL, Shelton M, Dennehy PH, Leach C, Rathore M, Abughali N, Wright P, Frenkel LM, Brady RC, Van Dyke R, Weiner LB, Guzman-Cottrill J, McCarthy CA, Griffin J, Jester P, Parker M, Lakeman FD, Kuo H, Lee CH, Cloud GA; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

N Engl J Med. 2011 Oct 6;365(14):1284-92. doi: 10.1056/NEJMoa1003509.

13.

Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.

Abdel-Rahman SM, Chandorkar G, Akins RL, Bradley JS, Jacobs RF, Donovan J, Benziger DP.

Pediatr Infect Dis J. 2011 Aug;30(8):712-4. doi: 10.1097/INF.0b013e31820fc8e1.

PMID:
21317681
14.

Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents.

Abdel-Rahman SM, Kearns GL, Topelberg S, Jacobs RF, Mistry GC, Majumdar A, Xu Y, Wagner JA, Kitchen CJ, Groff M, Herman G, Blumer JL.

Pediatr Infect Dis J. 2010 Dec;29(12):1072-6. doi: 10.1097/INF.0b013e3181e82608.

15.

Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.

Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.

Clin Infect Dis. 2010 Jan 15;50(2):221-8. doi: 10.1086/649212.

PMID:
20014952
16.

Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.

Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, Bradley JS, Wade KC, Ramilo O, Romero JR, Shelton M, Leach C, Guzman-Cottrill J, Robinson J, Abughali N, Englund J, Griffin J, Jester P, Cloud GA, Whitley RJ; NIAID Collaborative Antiviral Study Group.

Pediatr Infect Dis J. 2010 Mar;29(3):195-8. doi: 10.1097/INF.0b013e3181bbf26b.

17.

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

Oliver SE, Cloud GA, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Soong SJ, Whitley RJ, Kimberlin DW; National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group.

J Clin Virol. 2009 Dec;46 Suppl 4:S22-6. doi: 10.1016/j.jcv.2009.08.012. Epub 2009 Sep 18.

18.

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL.

Pediatr Infect Dis J. 2008 Apr;27(4):330-4. doi: 10.1097/INF.0b013e318160edfc.

PMID:
18316988
19.

Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.

Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud GA, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

J Infect Dis. 2008 Mar 15;197(6):836-45. doi: 10.1086/528376.

PMID:
18279073
20.

Human monocytic ehrlichiosis in children.

Schutze GE, Buckingham SC, Marshall GS, Woods CR, Jackson MA, Patterson LE, Jacobs RF; Tick-borne Infections in Children Study (TICS) Group.

Pediatr Infect Dis J. 2007 Jun;26(6):475-9.

PMID:
17529862
21.

Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.

Abdel-Rahman SM, Jacobs RF, Massarella J, Kauffman RE, Bradley JS, Kimko HC, Kearns GL, Shalayda K, Curtin C, Maldonado SD, Blumer JL.

Antimicrob Agents Chemother. 2007 Aug;51(8):2668-73. Epub 2007 May 21.

22.

Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.

Acosta EP, Brundage RC, King JR, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud G, Whitley R, Kimberlin DW; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Clin Pharmacol Ther. 2007 Jun;81(6):867-72. Epub 2007 Mar 28.

PMID:
17392728
23.

Human papillomavirus infection: the role of vaccination in pediatric patients.

Nichols JR, Stovall SH, Jacobs RF.

Clin Pharmacol Ther. 2007 Apr;81(4):607-10. Epub 2007 Feb 21. Review.

PMID:
17314926
24.

Impact of addition of philosophical exemptions on childhood immunization rates.

Thompson JW, Tyson S, Card-Higginson P, Jacobs RF, Wheeler JG, Simpson P, Bost JE, Ryan KW, Salmon DA.

Am J Prev Med. 2007 Mar;32(3):194-201.

PMID:
17296471
25.

Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children.

Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, Jacobs RF; Tick-borne Infections in Children Study Group.

J Pediatr. 2007 Feb;150(2):180-4, 184.e1.

PMID:
17236897
26.

Population pharmacokinetic model for gatifloxacin in pediatric patients.

Rubino CM, Capparelli EV, Bradley JS, Blumer JL, Kearns GL, Reed M, Jacobs RF, Cirincione B, Grasela DM.

Antimicrob Agents Chemother. 2007 Apr;51(4):1246-52. Epub 2007 Jan 12.

27.

Pharmacokinetics of rifapentine in children.

Blake MJ, Abdel-Rahman SM, Jacobs RF, Lowery NK, Sterling TR, Kearns GL.

Pediatr Infect Dis J. 2006 May;25(5):405-9.

PMID:
16645503
28.

Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae.

Erwin AL, Nelson KL, Mhlanga-Mutangadura T, Bonthuis PJ, Geelhood JL, Morlin G, Unrath WC, Campos J, Crook DW, Farley MM, Henderson FW, Jacobs RF, Mühlemann K, Satola SW, van Alphen L, Golomb M, Smith AL.

Infect Immun. 2005 Sep;73(9):5853-63.

29.

Intravenous voriconazole therapy in a preterm infant.

Muldrew KM, Maples HD, Stowe CD, Jacobs RF.

Pharmacotherapy. 2005 Jun;25(6):893-8.

PMID:
15927909
30.

Public health and the politics of school immunization requirements.

Salmon DA, Sapsin JW, Teret S, Jacobs RF, Thompson JW, Ryan K, Halsey NA.

Am J Public Health. 2005 May;95(5):778-83. Review.

31.

Pharmacokinetics of gatifloxacin in infants and children.

Capparelli EV, Reed MD, Bradley JS, Kearns GL, Jacobs RF, Damle BD, Blumer JL, Grasela DM.

Antimicrob Agents Chemother. 2005 Mar;49(3):1106-12.

32.

Relationship between intracranial granulomas and cerebrospinal fluid levels of gamma interferon and interleukin-10 in patients with tuberculous meningitis.

Mansour AM, Frenck RW Jr, Darville T, Nakhla IA, Wierzba TF, Sultan Y, Bassiouny MI, McCarthy K, Jacobs RF.

Clin Diagn Lab Immunol. 2005 Feb;12(2):363-5.

33.

Pharmacokinetics of intravenously administered azithromycin in pediatric patients.

Jacobs RF, Maples HD, Aranda JV, Espinoza GM, Knirsch C, Chandra R, Fisher JM, Kearns GL.

Pediatr Infect Dis J. 2005 Jan;24(1):34-9.

PMID:
15665708
34.

Therapy for Mycobacterium bovis.

Murray DL, Jacobs RF.

Pediatr Infect Dis J. 2004 Nov;23(11):1072; author reply 1072-3. No abstract available.

PMID:
15545876
35.

Clinical and Laboratory Issues in Community-acquired MRSA.

Beavers-May T, Jacobs RF.

J Pediatr Pharmacol Ther. 2004 Apr;9(2):82-8. doi: 10.5863/1551-6776-9.2.82.

36.

Management of acute hematogenous osteomyelitis in children.

Darville T, Jacobs RF.

Pediatr Infect Dis J. 2004 Mar;23(3):255-7. Review. No abstract available.

PMID:
15014303
37.

Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.

Schutze GE, Gilliam CH, Jin S, Cavenaugh CK, Hall RW, Bradsher RW, Jacobs RF.

Pediatr Infect Dis J. 2004 Feb;23(2):110-4.

PMID:
14872174
38.

Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.

Maples HD, Stowe CD, Saccente SL, Jacobs RF.

Pediatr Infect Dis J. 2003 Nov;22(11):1022-4. No abstract available.

PMID:
14628778
39.

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong SJ, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

J Pediatr. 2003 Jul;143(1):16-25.

PMID:
12915819
40.

Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

O'Neill JM, St Geme JW 3rd, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, Schutze GE.

J Clin Microbiol. 2003 Jul;41(7):3064-9.

41.

Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States.

Marshall GS, Stout GG, Jacobs RF, Schutze GE, Paxton H, Buckingham SC, DeVincenzo JP, Jackson MA, San Joaquin VH, Standaert SM, Woods CR; Tick-Borne Infections in Children Study Group.

Arch Pediatr Adolesc Med. 2003 May;157(5):443-8.

PMID:
12742879
42.

Destructive osteomyelitis of the fibular epiphysis due to Kingella kingae.

O'Neill JM, Beavers-May T, Wheeler JG, Jacobs RF.

J Ark Med Soc. 2003 Mar;99(9):293-4. No abstract available.

PMID:
12674914
43.

Parental emotional and time costs predict compliance with respiratory syncytial virus prophylaxis.

Robbins JM, Tilford JM, Gillaspy SR, Shaw JL, Simpson DD, Jacobs RF, Wheeler JG.

Ambul Pediatr. 2002 Nov-Dec;2(6):444-8.

PMID:
12437390
44.

Human monocytic ehrlichiosis: similar to Rocky Mountain spotted fever but different.

Jacobs RF.

Pediatr Ann. 2002 Mar;31(3):180-4. Review. No abstract available.

PMID:
11905291
45.

Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States.

Marshall GS, Jacobs RF, Schutze GE, Paxton H, Buckingham SC, DeVincenzo JP, Jackson MA, San Joaquin VH, Standaert SM, Woods CR; Tick-Borne Infections in Children Study Group.

Arch Pediatr Adolesc Med. 2002 Feb;156(2):166-70.

PMID:
11814379
46.

Prevention of respiratory syncytial virus infection in high risk infants.

Prince AM, Jacobs RF.

J Ark Med Soc. 2001 Oct;98(4):115-8. Review.

PMID:
11594047
47.

Impact of a waiting room videotape message on parent attitudes toward pediatric antibiotic use.

Wheeler JG, Fair M, Simpson PM, Rowlands LA, Aitken ME, Jacobs RF.

Pediatrics. 2001 Sep;108(3):591-6.

PMID:
11533323
48.

Radiological case of the month: Lemierre syndrome.

Narsinghani U, Schmidt MB, Jacobs RF, Anand KS.

Arch Pediatr Adolesc Med. 2001 Aug;155(8):965-6. No abstract available.

PMID:
11483128
49.

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Weller S, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Pediatrics. 2001 Aug;108(2):230-8.

PMID:
11483782
50.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Pediatrics. 2001 Aug;108(2):223-9.

PMID:
11483781

Supplemental Content

Loading ...
Support Center